May 21, 2024
Global Antidote Market

The Global Antidote Market is driven by growing number of poisoning cases

The global antidote market deals with pharmaceutical products that act as an antidote or antiserum in case of poisoning or bites from venomous animals and insects. Antidotes help neutralize or counteract the effects of toxins or poisons helping save lives. Antidotes are used to treat poisonings from drugs, chemicals, substances or animal venoms. They come in forms like injection, tablets, syrups and gels depending on the type of poisoning. The development of universal antidotes for treating multiple types of poisoning is a major focus area. The Global Antidote Market is estimated to be valued at US$ 2.70 BN in 2024 and is expected to exhibit a CAGR of 7.8% over the forecast period 2024 to 2030.

Key Takeaways

Key players operating in the global antidote market are Dr. Reddy’s Laboratories Ltd Viatris Inc., Fresenius Kabi AG, Zydus Lifesciences Ltd., Endo International plc, Novartis AG, Baxter International, Inc., Emergent BioSolutions Inc., Pfizer Inc., Hikma Pharmaceuticals PLC, Incepta Pharma, VINS Bioproducts Ltd Bharat Serums and Vaccines Limited, CSL Limited, Mediclone Biotech, Shanghai Serum Bio-technology Co., LTD., Haffkine Bio-pharmaceutical Corporation Ltd. and Premium Serums. Key players are focused on expanding their antidote product portfolio and geographical presence through mergers and acquisitions.

There is a growing demand for antidotes due to increasing poisoning cases from accidental or intentional drug overdoses, environmental pollutants, chemicals, insects and animal bites across regions. The rising incidence of snakebites in developing countries and increased awareness about availability of antidotes are supporting market growth.

The Global Antidote Market Demand players are focused on expanding their business operations in emerging markets of Asia Pacific, Latin America, Africa and Middle East. Factors like growing healthcare investments, large patient pools, and increasing healthcare awareness are encouraging international companies to tap opportunities in developing economies.

Market drivers

The growing number of poisoning cases due to drug overdoses, accidents and animal bites across the world is a major factor driving the antidote market growth. According to WHO, there are 4.4 million poisonings globally each year resulting in 2,20,000 deaths. Easy availability of toxic substances, lack of knowledge about safe chemical handling, rising substance abuse cases are increasing poisoning incidents. Moreover, increasing risk of environmental pollution from industrial waste and chemicals has heightened the need for antidotes. The increasing safety regulations mandating availability of antidotes in hospitals, medical facilities and manufacturing plants to handle emergencies is further supporting market expansion.

Current geopolitical situation and its impact on the Global Antidote Market growth
The ongoing geopolitical tensions between major global powers like Russia and Ukraine, China and Taiwan has impacted cross-border trade and logistics across several industries including pharmaceuticals. The supply chains for key ingredients and raw materials required for antidotes have been disrupted due to import/export restrictions, sanctions and rising freight costs. This has hampered the production volume and capacities of antidote manufacturers in European and Asian markets in short to medium term.
The rising raw material prices and shortage of materials has forced antidote makers to increase their product prices in international markets. This is expected to slowdown the volume growth for antidotes used for chemical poisoning, snake bites and other envenomation in developing regions of Africa and South Asia where budgetary constraints are a major concern for healthcare systems. The global antidote market growth relying majorly on sales volumes may witness downward pressure in the forecast period. The market players need to focus on developing long term supplies of crucial antidote ingredients and alternative low cost sources to minimize prolonged supply chain disruptions due to changing geopolitical dynamics among major trading partners.

Regions contributing major share to the Global Antidote Market
North America region currently holds the largest share of the global antidote market in terms of value sales. This is attributed to high medical awareness, stringent regulations and treatment protocols particularly for chemical poisonings and opioid overdoses as well as presence of majority of the key players in the region. The Asia Pacific region excl. Japan and Middle East & Africa region are expected to show fastest growth rates in the global antidote market during the forecast period due to rising income levels, growing healthcare investments and increasing prevalence of snake bites, scorpion stings and other forms of envenomation as well other poisoning cases requiring antidotes in rural agricultural regions.

Fastest growing region in the Global Antidote Market
Asia Pacific region excluding Japan is poised to grow at the fastest pace in the overall antidote market during 2024-2030. Factors such as rapidly developing pharmaceutical industry, favourable regulatory approvals, growing healthcare access and rising awareness about available antidotes, and presence of key regional players are supporting this growth. Moreover, the high prevalence of snake bites, poisonous animal stings and other forms of poisoning among the agricultural populations particularly in developing countries like India, Bangladesh, Indonesia etc. has necessitated wider availability and uptake of various antidotes in both hospital and pre-hospital emergency settings. The market players in this region therefore need to focus on continuous new product development, as well as expansion of antidote manufacturing facilities and distribution networks to tap the future high growth potential.

*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it